Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases-Reference-Cited by-同舟云学术

Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases

Published:2017-07-27 Issue:9 Volume:16 Page:883-894
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Barrett P. Noel¹,Terpening Sara J.¹,Snow Doris¹,Cobb Ronald R.¹,Kistner Otfried¹

Affiliation:

1. Nanotherapeutics Inc., Alachua, FL, USA

Funder

Department of Health and Human Services, Ofﬁce of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2017.1357471

Reference80 articles.

1. A short history of vaccination

2. Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

3. Poliovirus vaccine—inactivated

4. The serial cultivation of human diploid cell strains

5. Rabies Vaccine Prepared in Human Cell Cultures: Progress and Perspectives

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations;Human Vaccines & Immunotherapeutics;2024-07-15

2. Enhancing Dengue Virus Production and Immunogenicity with Celcradle™ Bioreactor: A Comparative Study with Traditional Cell Culture Methods;Vaccines;2024-05-22

3. Vaccination and Control Methods of West Nile Virus Infection in Equids and Humans;Vaccines;2024-05-01

4. Electrochemical assay of mammalian cell viability;Bioelectrochemistry;2024-04

5. The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge;PLOS ONE;2024-01-24